Effects of mission duration on neuroimmune responses in astronauts.

BACKGROUND Spaceflight poses a unique stress to humans that can impair cellular immune responses and reactivate latent herpes viruses. Notably, prior studies have suggested that mission length may be an important factor in the variability of immune alterations observed after spaceflight. In this study, adrenocortical responses and circulating leukocytes were compared between astronauts who participated in either 9- or 16-d missions. HYPOTHESIS Mission duration will differentially affect neuroimmune responses after spaceflight. METHODS Blood and urine samples, collected from 28 crew-members who flew on 5 Space Shuttle missions, were analyzed for levels of plasma and urinary cortisol, urinary catecholamines, leukocyte and lymphocyte subsets, and total IgE. RESULTS After spaceflight, plasma cortisol was significantly decreased after the 9-d missions but increased after the 16-d missions. In contrast urinary epinephrine and norepinephrine levels were greater after the 9-d missions than the 16-d missions. Total IgE was significantly increased after the 16-d missions and correlated with urinary cortisol. The number of white blood cells, polymorphonuclear leukocytes, and CD4+ T cells were significantly increased postflight. After the 9-d missions, monocytes were increased while natural killer cells were decreased. However, monocytes were decreased after the 16-d missions; no change occurred in natural killer cells. CONCLUSIONS These results suggest that sympathetic nervous system responses predominate after shorter spaceflights, while longer flights are characterized by glucocorticoid-mediated changes at landing that may result from the accumulative effects of microgravity (i.e., physiological deconditioning) over time.

[1]  A. Fauci,et al.  Alternate-day prednisone therapy and human lymphocyte subpopulations. , 1975, The Journal of clinical investigation.

[2]  P J Mills,et al.  Peripheral Leukocyte Subpopulations and Catecholamine Levels in Astronauts as a Function of Mission Duration , 2001, Psychosomatic medicine.

[3]  G Sonnenfeld,et al.  Changes in the immune system during and after spaceflight. , 1997, Advances in space biology and medicine.

[4]  D. Pierson,et al.  Elevated Stress Hormone Levels Relate to Epstein-Barr Virus Reactivation in Astronauts , 2001, Psychosomatic medicine.

[5]  D. Mason,et al.  Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. , 1996, Journal of immunology.

[6]  G Sonnenfeld,et al.  Immune Responses in Space Flight , 1998, International journal of sports medicine.

[7]  G. Taylor Immune changes during short‐duration missions , 1993, Journal of leukocyte biology.

[8]  D. Pierson,et al.  Reactivation and shedding of cytomegalovirus in astronauts during spaceflight. , 2000, The Journal of infectious diseases.

[9]  Daniel L. Feeback,et al.  Leukocyte subsets and neutrophil function after short‐term spaceflight , 1999, Journal of leukocyte biology.

[10]  D. Papanicolaou,et al.  Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. , 1996, Proceedings of the Association of American Physicians.

[11]  M. Schedlowski,et al.  Catecholamine-Induced Leukocytosis: Early Observations, Current Research, and Future Directions , 1996, Brain, Behavior, and Immunity.

[12]  C. Akdis,et al.  Glucocorticoids inhibit human antigen‐specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro , 1997, European journal of immunology.

[13]  C S Leach Biochemical and hematologic changes after short-term space flight. , 1992, Microgravity quarterly : MGQ.

[14]  Daniel L. Feeback,et al.  Immune responses and latent herpesvirus reactivation in spaceflight. , 2001, Aviation, space, and environmental medicine.

[15]  D. Umetsu,et al.  Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. , 1997, Journal of immunology.

[16]  A. Fauci,et al.  Corticosteroid‐Mediated Immunoregulation in Man , 1982, Immunological reviews.

[17]  A. Fauci,et al.  Glucocorticosteroid therapy: mechanisms of action and clinical considerations. , 1976, Annals of internal medicine.

[18]  Kehrl Jh,et al.  The clinical use of glucocorticoids. , 1983 .

[19]  T P Stein,et al.  Nutrition and muscle loss in humans during spaceflight. , 1999, Advances in space biology and medicine.

[20]  A Cogoli,et al.  Cellular immunity in cosmonauts during long duration spaceflight on board the orbital MIR station. , 1994, Aviation, space, and environmental medicine.

[21]  E. Gelfand,et al.  In vivo effects of glucocorticoids on IgE production. , 1994, The Journal of allergy and clinical immunology.

[22]  D. Pierson,et al.  Incidence of Epstein-Barr virus in astronaut saliva during spaceflight. , 1999, Aviation, space, and environmental medicine.

[23]  C. Sams,et al.  The role of psychoneuroendocrine factors on spaceflight‐induced immunological alterations , 1993, Journal of leukocyte biology.

[24]  J I Leonard,et al.  Regulation of body fluid compartments during short-term spaceflight. , 1996, Journal of applied physiology.

[25]  L S Neale,et al.  Alteration in human mononuclear leucocytes following space flight. , 1992, Immunology.

[26]  G R Taylor,et al.  Immunological analyses of U.S. Space Shuttle crewmembers. , 1986, Aviation, space, and environmental medicine.

[27]  A. Fauci,et al.  The clinical use of glucocorticoids. , 1983, Annals of allergy.